• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Development and Study of Recombinant Immunoglobulin A to Hemagglutinins of the Influenza Virus

tetano

Editor, Senior Moderator
Acta Naturae. 2018 Apr-Jun;10(2):30-36.
[h=1]The Development and Study of Recombinant Immunoglobulin A to Hemagglutinins of the Influenza Virus.[/h] Aliev TK[SUP]1[/SUP], Dement'yeva IG[SUP]2[/SUP], Toporova VA[SUP]3[/SUP], Argentova VV[SUP]4[/SUP], Pozdnyakova LP[SUP]2[/SUP], Bokov MN[SUP]2[/SUP], Votchitseva YA[SUP]4[/SUP], Dolgikh DA[SUP]3,[/SUP][SUP]4[/SUP], Varfolomeyev SD[SUP]1[/SUP], Sveshnikov PG[SUP]2[/SUP], Kirpichnikov MP[SUP]3,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] We obtained recombinant variants of human antibody FI6 broadly specific to hemagglutinins of the influenza A virus. On the basis of a bi-promoter (CMV, hEF1-HTLV) vector, we developed genetic constructs for the expression of the heavy and light chains of the immunoglobulins of IgA1-, IgA2m1-, and IgG-isotypes. Following transfection and selection, stable Chinese hamster ovary (CHO) cell lines were produced. The antibodies of IgA1-, IgA2m1-, and IgG-isotypes were purified from culture media. We performed an immunochemical characterization and studied their interactions with influenza A strains of the H1N1- and H3N2-subtypes. It was shown that recombinant FI6 variants of the IgA-isotype retain the properties of the parental IgG antibody to demonstrate specificity to all the strains tested. The strongest binding was observed for the H1N1 subtype, which belongs to hemagglutinins of phylogenetic group I.


[h=4]KEYWORDS:[/h] IgA1; IgA2m1; Influenza A virus; broadly neutralizing antibodies; immunoglobulin A; recombinant antibodies

PMID: 30116613 PMCID: PMC6087826
Free PMC Article
 
Back
Top Bottom